I. Duka et al., Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction, GEN PH-VASC, 34(2), 2000, pp. 101-106
Catecholamines induce direct vasoconstriction mediated by postsynaptic alph
a-adrenergic receptors (alpha-ARs) of both the alpha(1) and alpha(2) type.
To evaluate the contribution of each alpha(2)-AR subtype (alpha(2A), alpha(
2B), and alpha(2C)) to this function, we used groups of genetically enginee
red mice deficient for the gene to each one of these subtypes and compared
their blood pressure (BP) responses to their wild-type counterparts. Blood
pressure responses to a bolus of norepinephrine (NE) were assessed before a
nd after sequential blockade of alpha(1)-ARs with prazosin and alpha(2)-ARs
with yohimbine. The first NE bolus elicited a brief 32 to 44 mm Hg BP rise
(p < 0.001 from baseline) in all six groups. Prazosin decreased BP by 23 t
o 33 mm Hg in all groups, establishing a new lower baseline. Repeat NE at t
hat point elicited lesser but still significant (p < 0.001) brief presser r
esponses between 32% and 45% of the previous BP rise in five of the six gro
ups. Only the alpha(2A)-AR gene knockouts differed, responding instead with
a 20-mm Hg fall in BP, a significant change from baseline (p < 0.001) and
different from the presser response of their wild-type counterparts (p < 0.
001). The addition of yohimbine produced no further BP change in the five g
roups, but it did produce a small 7.5-mm Hg fall (p < 0.05) in the alpha(2A
)-AR knockouts. Norepinephrine bolus during concurrent alpha(1) and alpha(2
)-AR blockade produced significant (p < 0.001) hypotensive responses in all
subgroups, presumably attributable to unopposed stimulation of beta(2)-vas
cular wall ARs. We conclude that the alpha(2)-AR-mediated vasoconstriction
induced by catecholamines is attributable to the alpha(2A)-AR subtype becau
se mice deficient in any one of the other subtypes retained the capacity fo
r normal vasoconstrictive responses. However, the alpha(1)-ARs account for
the major part (as much as 68%) of catecholamine-induced vasoconstriction.
(C) 2000 Elsevier Science Inc. All rights reserved.